Legend Biotech Corporation
Legend Biotech Corporation（LEGN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
legn · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 19 位华尔街分析师
Buy
19 位分析师
共识
评级分布
12 个月目标价
High
$75.00
Consensus
$59.78
+83.3% upside
Low
$24.00
Median: $65 · Last Close: $32.62
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$59.78
83.3% upside
High Target
$75
129.9%
Low Target
$24
-26.4%
Current Price
$32.62
as of today
Based on analyst price targets, the LEGN stock price prediction for the next 12 months ranges from $24 to $75. The consensus LEGN price forecast of $59.78 implies 83.3% upside from the current price of $32.62.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $32.62 | ↑ 0.00% |
1-day model range: $32.39–$32.85. Peak: $32.85 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LEGN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-06-03 | UBS | Maintains | Buy→Buy |
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-13 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-13 | TD Cowen | Maintains | Hold→Hold |
| 2026-04-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-11 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-03-11 | RBC Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Legend Biotech Corporation (LEGN) stock. Of the recent 124 rating actions, 2 were upgrades and 2 were downgrades. 19 analysts currently cover LEGN.
分析师推荐趋势
LEGN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.4B
↓ 32.3% YoY
Revenue Next Year
$1.8B
↑ 26.2% YoY
EPS This Year
$0.09
EPS Next Year
$0.92
↑ 909.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast LEGN EPS of $0.09 for the current fiscal year, based on estimates from 4 analysts. The LEGN revenue forecast is $1.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LEGN 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LEGN 的共识目标价为 $59.78（+83.3% 上行空间），分析师共识为 Buy。
LEGN 的短期预测（明日）为 $32.62（+0.00%）。
Legend Biotech Corporation 在 NASDAQ 上市，代码 LEGN。LEGN 在 2027 年的整体展望偏积极，在覆盖分析师中约 84% 对应 Buy 共识。
常见问题
LEGN 预测 · 8 个问题根据 19 位华尔街分析师，LEGN 的 12 个月平均目标价为 $59.78，最高 $75.00、最低 $24.00。若有图表，中位目标价可在上方查看。相对当前价 $32.62，隐含约 +83.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.